Format

Send to

Choose Destination
Nutr Rev. 2002 Dec;60(12):410-3.

Homocysteine, folate deficiency, and Parkinson's disease.

Author information

1
University of California, Davis, Medical Center, Department of Medical Pathology, Research Building III, Room 3200A, 4645 Second Ave, Sacramento, CA 95817, USA.

Abstract

Folate deficiency sensitizes mice to dopaminergic neurodegeneration and motor dysfunction caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Additional experiments indicate that this effect of folate deficiency may be mediated by homocysteine. These findings suggest that folate deficiency and hyperhomocysteinemia are risk factors for Parkinson's disease.

PMID:
12521146
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center